1. Home
  2. CRL vs KNSL Comparison

CRL vs KNSL Comparison

Compare CRL & KNSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

HOLD

Current Price

$161.25

Market Cap

8.6B

Sector

Health Care

ML Signal

HOLD

Logo Kinsale Capital Group Inc.

KNSL

Kinsale Capital Group Inc.

HOLD

Current Price

$311.35

Market Cap

8.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRL
KNSL
Founded
1947
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
8.6B
8.3B
IPO Year
1999
2016

Fundamental Metrics

Financial Performance
Metric
CRL
KNSL
Price
$161.25
$311.35
Analyst Decision
Buy
Hold
Analyst Count
12
11
Target Price
$198.27
$403.45
AVG Volume (30 Days)
790.6K
319.5K
Earning Date
05-07-2026
04-23-2026
Dividend Yield
N/A
0.30%
EPS Growth
N/A
21.77
EPS
N/A
4.88
Revenue
$1,857,601,000.00
$1,873,987,000.00
Revenue This Year
N/A
$5.60
Revenue Next Year
$3.04
$7.88
P/E Ratio
N/A
$64.09
Revenue Growth
10.48
18.04
52 Week Low
$132.58
$293.78
52 Week High
$228.88
$512.76

Technical Indicators

Market Signals
Indicator
CRL
KNSL
Relative Strength Index (RSI) 45.38 42.39
Support Level $147.22 $293.78
Resistance Level $166.62 $364.61
Average True Range (ATR) 8.97 10.26
MACD -1.18 1.94
Stochastic Oscillator 31.12 47.09

Price Performance

Historical Comparison
CRL
KNSL

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

About KNSL Kinsale Capital Group Inc.

Kinsale Capital Group Inc is an insurance holding company. The company is engaged in offering property, casualty, and specialty insurance products. It offers specialty insurance products for allied health, healthcare, life sciences, professional, and a public entity. The company operates in only one reportable segment which is the Excess and Surplus Lines Insurance segment, which includes commercial excess and surplus lines liability and property insurance products through its underwriting divisions. The company generates revenues in the form of premiums and investment income.

Share on Social Networks: